CatalystBio continues to make the rounds! Michael Boyne, Co-Founder and Principal, will be sharing his deep expertise at the CASSS – Sharing Science Solutions Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry in Costa Mesa, CA. Michael will be sharing his… Read More
Thank you to everyone who attended this session and joined in on the lively discussion! Special thanks to our host Biocom California, moderator Franklin Rice at The Sights Group, and panelist Mark Kaufmann at Acurex Biosciences. Read More
Planning your first Pre-IND meeting with the FDA? CatalystBio’s white paper explores when to engage, how to prepare, and key best practices to get the most out of your Pre-IND meeting. Read more here: https://lnkd.in/gXmgbdB2 CatalystBio provides expert guidance to biotech companies at… Read More
🌐 It was an international effort as we kicked off a fantastic collaborative seminar at the Korean Pavilion at #BIO2025, highlighting the opportunities of running clinical trials in Australia, Korea and California. 🔺 Our Director Partnerships Jarrod Belcher GAICD opened the seminar explaining that each… Read More
At #BIO2025, Michael Boyne, Co-founder and Principal at CatalystBio, spoke on clinical trial development in the U.S. as part of a panel examining regional approaches to conducting trials and the diverse opportunities available across different countries. The audience also heard valuable insights from Jinhak Kim… Read More
We’re excited to share that CatalystBio will be attending the CASSS – Sharing Science Solutions Cell and Gene Therapy Products (CGTP) Symposium 2025! Greta Wodarcyk and Michael Boyne will be representing our team, joining important discussions on the latest challenges and advancements in cell and… Read More
Yesterday, Greta Wodarcyk and Michael Boyne had the exciting opportunity to speak with a group of trainees in Northwestern University’s Biotechnology Training Program about a critical milestone in drug development: the path to an Investigational New Drug (IND) application. Their seminar, “Path to IND — Moving from the… Read More
The CatalystBio team is thrilled to announce the launch of our website! We’re excited to have a place where we can share more about who we are, what we do, and how we partner with innovators across the biotech landscape. From early-stage discovery through regulatory… Read More
We’re pleased to announce that Michael Boyne, Co-Founder and Principal at CatalystBio, will be sharing his expertise at the American Institute for Medical and Biological Engineering (AIMBE) Annual Meeting this Sunday, March 30th. Michael will be speaking on one of his favorite topics: Translating Discoveries from the Bench to the Bedside – bridging the critical gap between...Read More
Recent Comments